Published in J Clin Microbiol on November 01, 2004
Resolving the structural features of genomic islands: a machine learning approach. Genome Res (2007) 1.54
Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis (2007) 1.26
Evolution of transcription regulatory genes is linked to niche specialization in the bacterial pathogen Streptococcus pyogenes. J Bacteriol (2005) 1.19
Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother (2006) 1.04
Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination. PLoS One (2010) 1.00
Lateral gene transfer of streptococcal ICE element RD2 (region of difference 2) encoding secreted proteins. BMC Microbiol (2011) 1.00
Molecular epidemiology and genomics of group A Streptococcus. Infect Genet Evol (2014) 1.00
Phage 3396 from a Streptococcus dysgalactiae subsp. equisimilis pathovar may have its origins in streptococcus pyogenes. J Bacteriol (2007) 0.97
Virulence gene pool detected in bovine group C Streptococcus dysgalactiae subsp. dysgalactiae isolates by use of a group A S. pyogenes virulence microarray. J Clin Microbiol (2011) 0.91
The Seventh International Conference on the Genetics of Streptococci, Lactococci, and Enterococci. J Bacteriol (2006) 0.85
Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis. Front Microbiol (2014) 0.85
Recombination drives genetic diversification of Streptococcus dysgalactiae subspecies equisimilis in a region of streptococcal endemicity. PLoS One (2011) 0.84
Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil. J Clin Microbiol (2010) 0.83
Distribution of emm types in invasive and non-invasive group A and G streptococci. Eur J Clin Microbiol Infect Dis (2011) 0.82
Flexible architecture of the Streptococcus pyogenes FCT genome region: finally the clue for understanding purulent skin diseases and long-term persistence? J Bacteriol (2006) 0.78
In vivo efficacy of a chimeric peptide derived from the conserved region of the M protein against group C and G streptococci. Clin Vaccine Immunol (2012) 0.75
Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc Natl Acad Sci U S A (1992) 3.37
Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells. J Infect Dis (1998) 2.49
Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect Immun (1992) 2.48
The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun (1997) 2.25
The identification of rofA, a positive-acting regulatory component of prtF expression: use of an m gamma delta-based shuttle mutagenesis strategy in Streptococcus pyogenes. Mol Microbiol (1994) 2.14
Medicine in tropical Australia. Med J Aust (1993) 1.86
Genomic localization of a T serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infect Immun (2002) 1.80
Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci. Infect Immun (1992) 1.68
Frequencies of streptococci of groups A, B, C, D, and G in urethra and cervix swab specimens from patients with suspected gonococcal infection. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.68
Retracted Directional gene movement from human-pathogenic to commensal-like streptococci. Infect Immun (2001) 1.61
M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest (1994) 1.60
Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect Immun (2001) 1.40
Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Infect (1988) 1.35
M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol (1995) 1.31
Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). FEMS Immunol Med Microbiol (2002) 1.30
Pyogenic streptococci of Lancefield groups C and G as pathogens in man. Soc Appl Bacteriol Symp Ser (1997) 1.27
Group G streptococcal infections. J Infect (1987) 1.22
Lateral genetic transfers between group A and G streptococci for M-like genes are ongoing. Microb Pathog (1996) 1.18
Molecular epidemiology of impetiginous group A streptococcal infections in aboriginal communities of northern Australia. J Clin Microbiol (1996) 1.16
Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp equisimilis in a patient with pyomyositis and reactive arthritis. J Clin Microbiol (2003) 1.11
Identification of a fibronectin-binding protein (GfbA) in pathogenic group G streptococci. Infect Immun (1996) 1.10
Distribution of hemolytic streptococci in respiratory specimens. J Clin Microbiol (1979) 1.07
Pharyngeal carriage of group C and group G streptococci and acute rheumatic fever in an Aboriginal population. Lancet (2000) 1.06
Evolution of sfbI encoding streptococcal fibronectin-binding protein I: horizontal genetic transfer and gene mosaic structure. J Clin Microbiol (2003) 0.92
An outbreak of puerperal fever caused by group C streptococci. J Hosp Infect (1989) 0.92
The gut as a source of the haemolytic streptococci causing infection in surgery of the intestinal and biliary tracts. J Infect (1983) 0.88
Streptococcal serotypes newly associated with epidemic post-streptococcal acute glomerulonephritis. J Med Microbiol (1990) 0.82
An outbreak of group C streptococcal infection in a maternity unit. J Hosp Infect (1994) 0.80
Rheumatic heart disease in aboriginal children in the Northern Territory. Med J Aust (1989) 0.80
Occurrence of beta-hemolytic streptococcus group G in school children and sick children. Southeast Asian J Trop Med Public Health (1990) 0.78
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Melioidosis. N Engl J Med (2012) 6.94
DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med (2007) 4.35
Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol (2006) 2.94
Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol (2009) 2.94
Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol (2011) 2.81
Nonrandom distribution of Burkholderia pseudomallei clones in relation to geographical location and virulence. J Clin Microbiol (2006) 2.34
Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis (2004) 2.33
Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis (2008) 2.24
Clinical toxinology--where are we now? J Toxicol Clin Toxicol (2003) 2.23
Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis (2009) 2.20
Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis (2006) 2.18
Housekeeping enzymes as virulence factors for pathogens. Int J Med Microbiol (2003) 1.96
Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis (2006) 1.94
Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis (2007) 1.90
Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J Clin Microbiol (2004) 1.88
Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg (2006) 1.82
A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions. J Bacteriol (2007) 1.82
Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics (2008) 1.82
Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev (2007) 1.81
Trigger for group A streptococcal M1T1 invasive disease. FASEB J (2006) 1.77
Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust (2012) 1.77
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76
Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl Trop Dis (2009) 1.74
Identification of a novel plasmin(ogen)-binding motif in surface displayed alpha-enolase of Streptococcus pneumoniae. Mol Microbiol (2003) 1.72
Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl Trop Dis (2013) 1.72
Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis (2006) 1.66
Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio (2013) 1.66
A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis (2007) 1.64
Sensitive and specific molecular detection of Burkholderia pseudomallei, the causative agent of melioidosis, in the soil of tropical northern Australia. Appl Environ Microbiol (2007) 1.62
Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis (2002) 1.60
An antimicrobial role for zinc in innate immune defense against group A streptococcus. J Infect Dis (2014) 1.60
Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis (2010) 1.57
Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis (2011) 1.57
Genetic diversity of Burkholderia pseudomallei isolates in Australia. J Clin Microbiol (2007) 1.56
Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Aust (2009) 1.55
Irukandji syndrome case series from Australia's Tropical Northern Territory. Ann Emerg Med (2009) 1.54
Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping. BMC Microbiol (2007) 1.54
Vibrio vulnificus and V. parahaemolyticus necrotising fasciitis in fishermen visiting an estuarine tropical northern Australian location. J Infect (2006) 1.51
Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ (2008) 1.51
A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol (2011) 1.51
Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot Cell (2005) 1.48
Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol (2007) 1.48
Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother (2004) 1.48
Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis (2012) 1.48
Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis (2008) 1.48
Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis (2003) 1.44
Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol (2005) 1.43
Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol (2006) 1.43
Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J Clin Microbiol (2012) 1.42
The M1 protein of Streptococcus pyogenes triggers an innate uptake mechanism into polarized human endothelial cells. J Innate Immun (2014) 1.42
New understanding of the group A Streptococcus pathogenesis cycle. Trends Microbiol (2007) 1.41
Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Med J Aust (2010) 1.41
VNTR analysis of selected outbreaks of Burkholderia pseudomallei in Australia. Infect Genet Evol (2006) 1.40
Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J Clin Microbiol (2003) 1.40
Identification of melioidosis outbreak by multilocus variable number tandem repeat analysis. Emerg Infect Dis (2009) 1.40
Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg (2006) 1.39
Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol (2002) 1.39
The streptococcal M protein: a highly versatile molecule. Trends Microbiol (2010) 1.38
Melioidosis in northern Australia, 2001-02. Commun Dis Intell Q Rep (2003) 1.37
Multiple antibiotic resistance gene recruitment onto the enterohemorrhagic Escherichia coli virulence plasmid. FASEB J (2009) 1.36
A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis (2009) 1.35
Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis (2002) 1.35
Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology (2003) 1.34
Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. J Infect Dis (2010) 1.29
Scabies: new future for a neglected disease. Adv Parasitol (2004) 1.29
Melioidosis at Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Med J Aust (2012) 1.29
Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics (2008) 1.28
Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis (2004) 1.27
Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust (2006) 1.27
Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis (2007) 1.26
Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Trop Med Int Health (2004) 1.24
Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. J Infect Dis (2003) 1.24
Using BOX-PCR to exclude a clonal outbreak of melioidosis. BMC Infect Dis (2007) 1.24
Clinical definitions of melioidosis. Am J Trop Med Hyg (2013) 1.24
Ectodomains 3 and 4 of human polymeric Immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem (2003) 1.23
A novel integrative conjugative element mediates genetic transfer from group G Streptococcus to other {beta}-hemolytic Streptococci. J Bacteriol (2009) 1.23
Inter-species genetic movement may blur the epidemiology of streptococcal diseases in endemic regions. Microbes Infect (2005) 1.22
Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines? Expert Rev Vaccines (2009) 1.22
Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol (2006) 1.20
Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells. Biochem J (2003) 1.19
A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS One (2008) 1.19
Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J Clin Microbiol (2008) 1.18
Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clin Infect Dis (2008) 1.16
Contamination of hand wash detergent linked to occupationally acquired melioidosis. Am J Trop Med Hyg (2004) 1.16
Immunoglobulin G (IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass. J Infect Dis (2003) 1.16
Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest (2003) 1.15
Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun (2007) 1.15